Katsuhiro Miura

Associate Professor

Nihon University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Katsuhiro Miura is an Associate Professor at Nihon University School of Medicine in Japan. His research primarily focuses on hematological malignancies, particularly diffuse large B-cell lymphoma and Hodgkin lymphoma, as well as patient management strategies for associated conditions. Recent publications highlight his work on macrophage polarization in the tumor microenvironment and the impacts of pegfilgrastim in chemotherapy. Dr. Miura's contributions significantly enhance the understanding and management of complex hematological diseases.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Olaf Merkel

Associate Prof. Dr.

Medical University of Vienna

AUSTRIA

View details

Harald Esterbauer

Head Molecular Diagnostics

Medical University of Vienna

AUSTRIA

View details

Berend Snijder

Assistant Professor

ETH Zürich

SWITZERLAND

View details

Marius Mayerhoefer

Professor

Weill Cornell Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katsuhiro Miura

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Contemporary management of diffuse large B-cell lymphoma in Japan

Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma

TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly

Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis

Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience

Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience

Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience

Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience

Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study

Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma

Clinical impact of central nervous system‐directed therapies on intravascular large B‐cell lymphoma: A single institution's experience

A novel rituximab administration protocol to minimize infusion-related adverse reactions in patients with B-cell lymphoma

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Collaborators (4)

Olaf Merkel

Harald Esterbauer

Berend Snijder

Marius Mayerhoefer

Make your next move.